Several Voyager Therapeutics Insiders Sell Shares Sending Potential Negative Signal

Voyager Therapeutics, Inc. (NASDAQ:VYGR) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When analyzing insider transactions, it is usually mo

Simply Wall StJun 21 08:02 ET

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment

Voyager TherapeuticsJun 13 00:00 ET

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the company

Voyager TherapeuticsJun 13 00:00 ET

Express News | HC Wainwright & Co. Reiterates Buy on Voyager Therapeutics, Maintains $30 Price Target

BenzingaMay 16 13:30 ET

Voyager Therapeutics: A Buy Rating on the Back of Strategic Advancements and a Promising Alzheimer's Candidate

TipRanksMay 16 11:45 ET

Express News | Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease

BenzingaMay 16 07:15 ET